Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Feature Previous | All Articles This Week | Next
This article originally posted 21 December, 2011 and appeared in  MedicationGLP-1 AgonistIssue 605Special Edition - Weight Loss

SPECIAL FEATURE: Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men

The regulation of food intake is a complex process involving psychologic, social, and physiologic components. Physiologically, it is generally assumed that food intake is regulated by a central feeding drive that is later counterregulated by peripheral satiety signals that are activated during a meal. These satiety signals have been suggested to include gut peptides and multiple signals via gastric and small-intestinal vagal afferent nerve fibers (1–4). Glucagon-like peptide 1(7-36) amide (GLP-1) is one peptide that has been implicated in the short-term regulation of food intake (5).

Advertisement

For the full article in PDF format just click on this link.

 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 21 December, 2011 and appeared in  MedicationGLP-1 AgonistIssue 605Special Edition - Weight Loss

Past five issues: Diabetes Clinical Mastery Series Issue 85 | Issue 626 | Special Edition - Getting Patients on Track | Diabetes Clinical Mastery Series Issue 84 | Issue 625 |

 
Diabetes In Control Advertisers
 
 
Cast Your Vote
Now that once-weekly GLP-1 is available, which product are you recommending for your type 2 patients?

Navigate Diabetes In Control
Announcement:
Search Articles On Diabetes In Control